BSE: IPCALAB - Ipca Laboratories Limited

Yield per half year: -0.5245%
Dividend yield: +0.27%

Share chart Ipca Laboratories Limited

Extended chart Simple chart
Financial Markets by TradingView

About Ipca Laboratories Limited

Ipca Laboratories Limited, a pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, CIS, and Australasia. It offers APIs in therapeutic areas of anti-hypertensive, anti-malarial, diuretic, DMARD, and anthelmintic.

more details
The company also provides generic and branded formulations in the therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, diabetes, dermatology, diabetology, emollients/protectives, fever, gastroenterology, hematology, helminthics, hepatoprotectives, immunosuppressant, infectious diseases, malaria, neurology, neuropathic pain, and NSAIDs, as well as nutraceuticals, ophthalmology, oral anti diabetes drug, orthopedics, probiotics, psychiatry, respiratory, rheumatology, and urology. It also exports its products worldwide. The company was incorporated in 1949 and is based in Mumbai, India.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

ISIN INE571A01038
Industry Pharmaceuticals
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 0.3888
Дивиденд ао 4
Сайт https://www.ipca.com
Цена ао 1443.05
Change price per day: +1.85% (1443.05)
Change price per week: +4.94% (1400.55)
Change price per month: +3.65% (1418.05)
Change price per 3 month: -7.76% (1593.35)
Change price per half year: -0.5245% (1477.5)
Change price per year: +22.67% (1198.15)
Change price per 3 year: +45.89% (1007.45)
Change price per 5 year: +3.47% (1420.4)
Change price per year to date: -11.7% (1664.55)
All parameters

Underestimation

Title Value Grade
P/S 3.99 4
P/BV 3.93 4
P/E 55.5 2
EV/EBITDA 19.72 6
Total: 5.25

Efficiency

Title Value Grade
ROA, % 5.55 2
ROE, % 8.99 3
Total: 2.83

Dividends

Title Value Grade
Div yield, % 0.271 0.68
DSI 0.8571 8.57
Total: 3.18

Debt

Title Value Grade
Debt/EBITDA 1.32 8
Total: 8.2

Growth impulse

Title Value Grade
Yield Revenue, % 63.93 8
Yield Ebitda, % 40.85 6
Yield EPS, % -10.08 0
Total: 4.8
More

Head Job title Payment Year of birth
Mr. Premchand Godha A.C. A., B. Com., CA Executive Chairman 112.65M 1946 (79 years)
Mr. Ajit Kumar Bhanwarlal Jain A.C.A., B.Sc. CFO, MD & Executive Director 77.54M 1955 (70 years)
Mr. Prashant Premchand Godha Executive Director 46M 1975 (50 years)
Mr. Pawan Kothari Vice President of Operations N/A 1965 (60 years)
Mr. Vishnu Saran Singh Kushwaha Vice President of Technical N/A 1968 (57 years)
Mr. Sunil Ghai President of Marketing N/A 1963 (62 years)
Mr. Sameer S. Tamhane Senior Vice President of Human Resources N/A 1967 (58 years)
Dr. Ashok Kumar President of R&D - Chemicals N/A 1954 (71 year)
Mr. Pranay Premchand Godha CEO, MD & Executive Director 50.98M 1972 (53 years)
Mr. Harish Pandurang Kamath Compliance Officer, Corporate Counsel & Company Secretary 1959 (66 years)

Address: India, Mumbai, 125 Kandivli Industrial Estate - open in Google maps, open in Yandex maps
Website: https://www.ipca.com